Safety and effectiveness of laparoscopic Y-en-Roux gastric bypass surgery in obese elderly patients.

Autor: Santos MPD; Department of Surgery, Hospital do Servidor Público Estadual, IAMSPE, Sao Paulo, SP, Brazil., Gonçalves JE; Department of Surgery, IAMSPE, Sao Paulo, SP, Brazil., Takahashi AAR; Department of Surgery, Faculdade de Medicina do ABC, Santo Andre, SP, Brazil., Britto BB; Department of Surgery, Faculdade de Medicina Tiradentes, Aracaju, SE, Brazil., Beraldo FB; Department of Surgery, IAMSPE, Sao Paulo, SP, Brazil., Waisberg J; Department of Surgery, IAMSPE, Sao Paulo, SP, Brazil., Tanno LK; Department of Pulmonology, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Paris, France.
Jazyk: angličtina
Zdroj: Acta cirurgica brasileira [Acta Cir Bras] 2020; Vol. 35 (6), pp. e202000606. Date of Electronic Publication: 2020 Jul 06.
DOI: 10.1590/s0102-865020200060000006
Abstrakt: Purpose To analyze, in aged obese patients, the weight loss, comorbidity control, and safety postoperative complications of bariatric surgery by Roux-en-Y gastric bypass technique. Methods Twenty-seven patients who underwent laparoscopic weight-reducing gastroplasty with Roux-en-Y gastric bypass to treat obesity were included. All patients were ≥ 60 years old at the time of surgery. The Wilcoxon test was used for statistical analysis, and a p-value ≤0.05it was considered significant. Results Ten (90.9%) patients with dyslipidemia were cured (p < 0.001). Nine (81.8%) patients with type 2 diabetes mellitus had total improvement and 2 (18.2%) had partial improvement (p = 0.003). In 23 patients with systemic arterial hypertension, 9 (39.1%) achieved total improvement and 14 (60.9%) partial improvement (p = 0.140). Five (71.4%) patients with obstructive sleep apnea syndrome were cured (p = <0.001). For other comorbidities, no partial improvement or cure was shown. Conclusions Roux-en-Y gastric bypass surgery in obese elderly patients can be performed safely and with low morbidity and mortality rates. The benefits of weight loss and reduced comorbidities are promising and like those of the younger population.
Databáze: MEDLINE